II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies

In the last few years, new primary immunodeficiencies and genetic defects have been described. Recently, immunoglobulin products with improved compositions and for subcutaneous use have become available in Brazil. In order to guide physicians on the use of human immunoglobulin to treat primary immun...

Full description

Saved in:
Bibliographic Details
Published in:Einstein (São Paulo, Brazil) Brazil), 2017-01, Vol.15 (1), p.1-16
Main Authors: Goudouris, Ekaterini Simões, Rego Silva, Almerinda Maria do, Ouricuri, Aluce Loureiro, Grumach, Anete Sevciovic, Condino-Neto, Antonio, Costa-Carvalho, Beatriz Tavares, Prando, Carolina Cardoso, Kokron, Cristina Maria, Vasconcelos, Dewton de Moraes, Tavares, Fabíola Scancetti, Silva Segundo, Gesmar Rodrigues, Barreto, Irma Cecília, Dorna, Mayra de Barros, Barros, Myrthes Anna, Forte, Wilma Carvalho Neves
Format: Article
Language:eng ; por
Subjects:
Administration, Cutaneous
Administration, Intravenous
Brazil
Consensus
Doenças do sistema imune
Humans
Immunoglobulins - therapeutic use
Immunologic Deficiency Syndromes
Immunologic Factors - supply & distribution
Immunologic Factors - therapeutic use
Imunização passiva
Imunoglobulinas
Imunoglobulinas intravenosas
MEDICINE, GENERAL & INTERNAL
Special
Síndromes de imunodeficiência
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the last few years, new primary immunodeficiencies and genetic defects have been described. Recently, immunoglobulin products with improved compositions and for subcutaneous use have become available in Brazil. In order to guide physicians on the use of human immunoglobulin to treat primary immunodeficiencies, based on a narrative literature review and their professional experience, the members of the Primary Immunodeficiency Group of the Brazilian Society of Allergy and Immunology prepared an updated document of the 1st Brazilian Consensus, published in 2010. The document presents new knowledge about the indications and efficacy of immunoglobulin therapy in primary immunodeficiencies, relevant production-related aspects, mode of use (routes of administration, pharmacokinetics, doses and intervals), adverse events (major, prevention, treatment and reporting), patient monitoring, presentations available and how to have access to this therapeutic resource in Brazil.
ISSN:1679-4508
2317-6385
2317-6385
1679-4508
DOI:10.1590/S1679-45082017AE3844